3 Results for "

Raf1-MEK-ERK

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "Raf1-MEK-ERK" in MCE Product Catalog:

Cat. No.: HY-N6670
CAS No.: 69712-56-7
Research Areas:  

Infection

Cefotetan is a binding agent that targets human Raf1 kinase inhibitor protein (hRKIP). Cefotetan binds to hRKIP, reduces the binding space between hRKIP and Raf1 kinase, relieves hRKIP's inhibition of the Ras/Raf1/MEK/ERK signaling pathway, and enhances ERK phosphorylation. Cefotetan can be used to study diseases associated with dysregulated Ras/Raf1/MEK/ERK signaling pathways. Cefotetan is also a broad-spectrum antibacterial agent that disrupts cell wall synthesis by binding to bacterial penicillin-binding proteins (PBPs). It is used to study bacterial infections such as bone, skin, urinary tract, and lower respiratory tract [1] .
loading...
    loading...
Cat. No.: HY-177511
CAS No.: 3022287-75-5
Target:  

Ras p38 MAPK Raf MEK ERK

Research Areas:  

Cancer

KRAS G12D-IN-30 (Compound 4) is a KRAS inhibitor. KRAS G12D-IN-30 inhibits the activation of the downstream MAPK signaling cascade (Raf1-MEK-ERK) by blocking the activity of the KRAS G12 mutant. KRAS G12D-IN-30 can be used for the research of cancer [1].
loading...
    loading...
Cat. No.: HY-179133
CAS No.: 3021527-82-9
Target:  

P2Y Receptor PKA Raf MEK ERK

Research Areas:  

Inflammation/Immunology

HDB-1 is a selective inhibitor of the P2Y14 receptor (P2Y14R) with an IC50 of 26 pM. HDB-1 shows no significant inhibition on P2Y1R, P2Y2R, P2Y4R, P2Y6R, and P2Y12R. HDB-1 blocks the activation of hepatic stellate cells (HSC) by inhibiting the PKA/Raf1/MEK/ERK signaling pathway mediated by P2Y14R, thereby alleviating the core pathological process of liver fibrosis. HDB-1 can be used for the study of liver fibrosis [1].
loading...
    loading...